fda bpc-157 unapproved drug warning EVEXIAS Life Sciences filing lawsuit over peptides FDA takes coser look at
Description
A man in his 70s presents with a nine month history of difficulty walking and climbing stairs, numbness and pain in his lower limbs, and paraesthesia in his hands
Impurities, contaminants, and mislabeled APIs are rampant
It requires more conversion steps, but its well-tolerated at higher doses and meaningfully raises NAD+ levels when dosed appropriately
Susie and Bruce Turnbull 73
